Adam Crystal
President, R&D · 12 filings · Latest: Oct 1, 2026
Tango Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
TNGX | Adam Crystal | President, R&D | Oct 1, 2026 | Sale | $24.47 | 27,000 | $660.8K | 115,743 | |
TNGX | Adam Crystal | President, R&D | Oct 1, 2026 | Option Exercise | $5.20 | 27,000 | $140.4K | 142,743 | |
TNGX | Adam Crystal | President, R&D | Sep 1, 2026 | Sale | $22.37 | 27,000 | $603.9K | 115,743 | |
TNGX | Adam Crystal | President, R&D | Sep 1, 2026 | Option Exercise | $5.20 | 27,000 | $140.4K | 142,743 | |
TNGX | Adam Crystal | President, R&D | Aug 3, 2026 | Sale | $27.24 | 27,000 | $735.5K | 115,743 | |
TNGX | Adam Crystal | President, R&D | Aug 3, 2026 | Option Exercise | $5.20 | 27,000 | $140.4K | 142,743 | |
TNGX | ADAM CRYSTAL | — | Aug 3, 2026 | Proposed Sale | $27.18 | 81,000 | $2.2M | — | |
TNGX | Adam Crystal | President, R&D | Jul 1, 2026 | Sale | $29.59 | 27,000 | $798.9K | 115,743 | |
TNGX | Adam Crystal | President, R&D | Jul 1, 2026 | Option Exercise | $5.20 | 27,000 | $140.4K | 142,743 | |
TNGX | Adam Crystal | President, R&D | Jun 1, 2026 | Sale | $22.87 | 27,000 | $617.6K | 115,743 | |
TNGX | Adam Crystal | President, R&D | Jun 1, 2026 | Option Exercise | $5.20 | 27,000 | $140.4K | 142,743 | |
TNGX | Adam Crystal | President, R&D | May 1, 2026 | Sale | $21.23 | 27,000 | $573.1K | 115,743 | |
TNGX | Adam Crystal | President, R&D | May 1, 2026 | Option Exercise | $5.20 | 27,000 | $140.4K | 142,743 | |
TNGX | ADAM CRYSTAL | — | May 1, 2026 | Proposed Sale | $21.62 | 65,460 | $1.4M | — | |
TNGX | Adam Crystal | President, R&D | Apr 15, 2026 | Sale | $25.00 | 38,460 | $961.5K | 112,622 | |
TNGX | Adam Crystal | President, R&D | Apr 15, 2026 | Option Exercise | $5.20 | 38,460 | $200.0K | 151,082 | |
TNGX | Adam Crystal | President, R&D | Apr 1, 2026 | Sale | $21.20 | 27,000 | $572.5K | 112,622 | |
TNGX | Adam Crystal | President, R&D | Apr 1, 2026 | Option Exercise | $5.20 | 27,000 | $140.4K | 139,622 | |
TNGX | Adam Crystal | President, R&D | Mar 25, 2026 | Sale | $20.11 | 12,000 | $241.3K | 112,622 | |
TNGX | Adam Crystal | President, R&D | Mar 25, 2026 | Option Exercise | $5.20 | 12,000 | $62.4K | 124,622 |
Page 1 of 2
Next →